Team:UCSF/Parts1

From 2013.igem.org

(Difference between revisions)
Line 517: Line 517:
1. Part: BBa_R0011, Link: <a href=http://parts.igem.org/Part:BBa_R0011:Experience>pLAC</a><br><br>
1. Part: BBa_R0011, Link: <a href=http://parts.igem.org/Part:BBa_R0011:Experience>pLAC</a><br><br>
2. Part: BBa_R0040, Link: <a href=http://parts.igem.org/Part:BBa_R0040:Experience>pTET</a><br><br>
2. Part: BBa_R0040, Link: <a href=http://parts.igem.org/Part:BBa_R0040:Experience>pTET</a><br><br>
-
<br><br><br>
+
<br><br>
</p2>
</p2>

Revision as of 17:52, 28 October 2013

BioBrick Parts Submitted to or Characterized in the Registry

Promoters

We characterized the pLAC and pTET inducible promoters and this information is available on the Experience page for each part.

1. Part: BBa_R0011, Link: pLAC

2. Part: BBa_R0040, Link: pTET



Guide RNAs (gRNA) for CRISPRi

We submitted 4 guide RNAs to the parts registry. The GFP and RFP gRNA's have been tested and shown to work in our experiments and in published results.

See the chart below for links to the parts registry pages for the RFP, GFP, XylE, and LacZ targeting gRNAs.
Media References:
CDC sets threat levels for drug-resistant 'superbugs'
Agricultural Antibiotic Use Contributes To 'Super-Bugs' In Humans

<groupparts>iGEM013 UCSF</groupparts>